+91 - 830 - 3146878
The purpose of this study was to evaluate the efficacy study of herbomineral drug LAS02 Capsule in Rectum and Colon patients who were admitted in Lavanya Ayurvedic Hospital & Research Center For Cancer and AIDS. The study was conducted after getting ethical clearance. Total 12 patients of Rectum and Colon. These patients were enrolled in Lavanaya hospital . These patients were suffering only from Rectum and Colon not any other diseases. All patients having medication ayuredic herbomineral drug LAS02 Capsule for more than one month treatment. After obtaining prior consent form these patients, venous blood samples was collected from the subjects before and after treatment with herbomineral drug LAS02 Capsule and measured the hematological and biochemical examinations along with Tumor Size. A percentage levels 99.01% of Tumor Size in Rectum and Colon cancer patients were reduced in 12 treated patients as compared to before treated 12 patients . There was also significant reduced parentage level0.71% ESR in patients after treatment with LAS02 Capsule more than one month as compared with before treatment. A significant reduction of hepatic enzymes (SGOT, SGPT, ALP ) in patients after treatment with drug. These findings suggested that LAS02 Capsule is most effective medicine for prevention Rectum and Colon Cancer.
The study was conducted after getting ethical clearance from Institutional human ethic committee. Total 12 Rectum and Colon cancer patients with age (16-70 years) were Lucknow city of Lavanya Ayurvedic Hospital and Research Center. These patients were only suffering from Rectum and Colon Cancer not from any organic diseases. After obtaining prior consent form, venous blood samples was collected from the subjects before (pre) and after treatment (post) with herbomineral drug LAS02 Capsule under aseptic condition. The drug was given to these patients for two months. After collection of blood sample, serum and plasma were separated by centrifugation at 4000 rpm for 10 min. at room temperature for measurement of hematological, biochemical parameters along with in pre and post treated patients.
All hematological and biochemistry parameters hemoglobin (Hb), alkaline phosphate (ALP), Serum glutamate oxaloacetate transminase (SGOT), Serum glutamate pyurvate transminase (SGPT) parameters were measured by fully automatic cell counter and clinical chemistry analyzer.
LDH activity was measured by kit according to protocol provided by supplier (Tranasia biomedical). The activity was expressed as an IU/ml.
Resulting data were expressed mean ± SD. Percentage parenthesis was observed between pre vs post treated patients with LAS02 drug in Colon cancer.
There were reduction Percentage level of Tumor Size in Rectum and Colon cancer 99.01% in patient Pre treated group is comparison to patient Post treated group and reduction. along with 79.86% reduction Percentage level of CA 15.3 biomarker in patient post treated group in comparison to patient pre treated group. VIEW CHART
ESR Percentage level was also found in 0.77% decreased in the patients after treatment with LAS02 Capsule in comparison to pre treatment. VIEW CHART
There were slightly increased Hb(%), hematocrit and RBC levels in patient treated group as compared with patient pre treated group. VIEW CHART
There were Percentage level 45.55% and 33.54% reduction of LDH and ALP enzyme activities in Rectum and Colon Cancer patients post treated group in comparison to patient pre treated group. VIEW CHART
On the basis of these findings it is suggested that the herbomineral drug LAS02 capsule is most effective and safe medicine for prevention of Rectum and Colon Cancer inpatients.
The purpose of this study was to evaluate the acute oral toxicity study of LAS02 in female Sprague Dawley rat model. [...]
The purpose of this study was to evaluate the maximum tolerated dose of LAS02 in Sprague dawley female rat. [...]
The aim of this study was to evaluate the maximum tolerated dose of LAS02 in female Sprague Dawley rat. [...]